Chromadex Corp


CDXC

Price

5.86


Change

-0.5


High

NA


Low

NA


Avg Volume

317,546


PE Ratio

NA


52 Week High

23.66


52 Week Low

4.36



Profile

ChromaDex is a dietary supplement and food ingredient company based in Los Angeles, California founded in 1999 that is publicly traded on the NASDAQ. In 2011, Dartmouth College announced it granted ChromaDex exclusive worldwide rights to a novel manufacturing process for nicotinamide riboside which it markets and sells as an ingredient under the brand name Tru Niagen. The firm also offers contract research services for sourcing raw materials, identifying new compounds, and developing processes for large scale manufacturing. ChromaDex licensed patents from the University of Mississippi and the USDA to commercially develop pterostilbene and sell the compound trademarked as pTeroPure via the company's BluScience product line. ChromaDex no longer sells PteroPure.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.